Brief: Kuros Biosciences appoints Joost de Bruijn as CEO
Nov 16 (Reuters) - KUROS BIOSCIENCES AG KURN.S
* PROMOTION OF DR. JOOST DE BRUIJN TO CHIEF EXECUTIVE
OFFICER
(CEO), EFFECTIVE DECEMBER 4, 2017
* IVAN COHEN-TANUGI HAS DECIDED TO STEP DOWN AS CEO AND
MEMBER OF
BOARD OF DIRECTORS
Source text for Eikon: ID:nTENgcjzna
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million